It’s a big day for Adamis Pharma (NASDAQ:ADMP). The drug maker announced a commercial partnership for its generic EpiPe Symjepi with Novartis (NYSE:NVS) subsidiary Sandoz, …
Ladenburg analyst Kevin Degeeter was out pounding the table on shares of Synergy Pharmaceuticals (NASDAQ:SGYP), initiating a Buy rating and price target of $3.00, which …
It’s a very rewarding trading day for investors in Gemphire Therapeutics (NASDAQ:GEMP) with shares up over 90%, making the stock Wall Street’s bull …
Yes, you’re reading this right. BTIG analyst Robert Hazlett is expecting Zosano Pharma (NASDAQ:ZSAN) shares to reach $19.
It can be tricky putting a rating and price tag on a biotech company, especially one that offers no profits but promises of …
RBC Capital analyst Mitch Steves is out today with a research note on shares of Nvidia (NASDAQ:NVDA), reiterating an Outperform rating, while raising the price …
Senseonics (NYSE American:SENS) shares fell as much as 8.5% today, following the news that the FDA has approved the company’s‘ Eversense continuous glucose …
Building on its strong growth momentum over the last few quarters, Micron (NASDAQ:MU) reported another beat/raise quarter. Emerging technologies such as cloud computing, big data, …
It’s a big day for Sarepta Therapeutics (NASDAQ:SRPT) investors. The company released positive preliminary results from a gene therapy for Duchenne muscular dystrophy (DMD) …
Google announced yesterday that it will invest $550 million in Chinese e-commerce powerhouse JD.com (NASDAQ:JD), part of the internet giant’s efforts to expand …
